COVID-19 vaccination at a clinic

August 8, 2024

COVD: The Late Phase/PASC/Long COVID

  • Long COVID Defined
    We read that “In recognition of the shortcomings of the existing definitions, the Administration for Strategic Preparedness and Response and the Office of the Assistant Secretary of Health in the Department of Health and Human Services tasked the National Academies of Sciences, Engineering, and Medicine (NASEM) with developing an improved definition for Long COVID that would take into account the needs of patients as well as the views and understanding of a range of experts. Here, we describe the process and rationale for the resulting 2024 NASEM long Covid definition.” These are the committee members and lead staff who produced the definition and they are sharing the experience and process of producing this definition. They share that the committee used a multiphase process of systematic engagement and information gathering. This process included the use of focus groups, a questionnaire, a public comment portal, and several public meetings, including a two-day symposium. More than 1,300 people participated in these activities, including patients and caregivers, public health and health care professionals, researchers, policy and advocacy professionals, payers, health care business professionals, and members of the public. Definition: Long Covid is an infection-associated chronic condition that occurs after SARS-CoV-2 infection and is present for at least three months as a continuous, relapsing and remitting, or progressive disease state that affects one or more organ systems. The authors conclude, “A standard definition should enable better tracking of the burden of Long COVID and facilitate the design and conduct of robust clinical trials that produce better treatments for this and other infection-associated chronic conditions. Above all, we hope that this definition contributes to compassionate and effective care for all patients in whom Long COVID is diagnosed.”

    https://www.nejm.org/doi/full/10.1056/NEJMsb2408466

Situation Dashboards

World_Health_Organization_logo_logotype

World Health Organization (WHO)

Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
university-logo-small-horizontal-blue-no-clear-space-51c7fb4524

Johns Hopkins University (JHU)

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
1point3acres

COVID-19 in US and Canada

1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
image

Genomic Epidemiology COVID-19

Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.

Sources for COVID-19 Information

World_Health_Organization_logo_logotype

World Health Organization (WHO)

1280px-US_CDC_logo.svg

Centers for Disease Control, US

ProMED-Logo

International Society for Infectious Diseases

twiv-logo

This Week in Virology (TWIV)

Receive updates about Parasites without Borders initiatives, developments, and learn more about parasites by subscribing to our periodic newsletter.


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Parasites Without Borders

Un recurso educativo integral sobre todos los aspectos de las enfermedades parasitarias y su impacto en la humanidad en todo el mundo.

Donate to Parasites Without Borders Today!

Ayude a llevar la información médica y biológica más reciente sobre enfermedades causadas por parásitos eucariotas a todos los médicos y estudiantes de medicina en los Estados Unidos.

Scroll al inicio